Connect with us

Hi, what are you looking for?

Jewish Business News

IPOs

Israeli Medical Laser Co Lumenis Set To Raise $100 Million On Nasdaq


The company is returning to Nasdaq after delisting in 2005.

Lumenis_One_IPL_handpiece

The Yokneam-based company Lumenis Ltd. announced that it is set to raise $100 million on the Nasdaq. The company develops, manufactures and markets medical laser equipment for the surgical, ophthalmology and aesthetic markets.

Lumenis will issue 6.25 million shares at $15-17 per share and will thus raise $93.8-106.3 million (a midpoint of $100 million) at a company valuation of $529-599 million (a midpoint of $564 million).

Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC and Jefferies LLC will serve as joint book-running managers for the proposed offering. Wells Fargo Securities, LLC will serve as co-manager.

umenis founded in 1991 as ESC Medical the company and after changing its name to Lumenis it held an IPO on Wall Street. In 2005 the company delisted after being acquired by VPartners, a unit of the Viola Group, and partners.

After heavy losses from 2004 to 2008 and few years of breaking even, the company has undergone a major recovery. In 2013, the company recorded a net profit of $17.4 million.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış